Considering only the cases with high expression of HMGA1 detected in stages III and IV, where the significant and most striking differences were obtained in mean OS values, our data supports the selection of 40% of the GC patients diagnosed in all tumor stages, except stage I, for treatment. Here, HMGA1 is linked to gastric cancer.